Literature DB >> 22095424

A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: Evolving technical choices and survival.

S Tonoli1, S M Magrini, L Costa, F Paiar, G Simontacchi, V Scotti, N Pasinetti, R Barca, D Barbieri, A De Stefani, E Cellai, M Buglione, G Biti.   

Abstract

PURPOSE: The authors sought to define treatment results according to the different accrual periods and clinical-therapeutic features in a large series of nasopharyngeal cancer (NPC) patients treated in two Italian centres over more than two decades.
MATERIALS AND METHODS: A total of 883 patients consecutively treated with radiotherapy between 1977 and 2000 at the Florence (FLO) and Brescia (IRA) Radiation Oncology centres were studied. Five-year overall (OS) and disease-specific (DSS) actuarial survival rates in the different pathological, clinical and therapeutic subgroups were calculated, along with the actuarial local-regional control (LRC) probability.
RESULTS: At univariate analysis, survival and local control rates were significantly better in the more recent accrual periods and in the more favourable disease presentations; treatment-related parameters mainly affect LRC. At multivariate analysis, patient- and disease-related factors had a more evident prognostic effect than did therapeutic factors, although dose to the nasopharynx and treatment technique had a marginally significant impact on DSS and OS.
CONCLUSIONS: Results of this benchmark study may be useful for understanding the development of new radio-therapy techniques for NPC, such as three-dimensional conformal radiotherapy (3D-CRT) and particularly intensity-modulated radiotherapy (IMRT).

Entities:  

Mesh:

Year:  2011        PMID: 22095424     DOI: 10.1007/s11547-011-0755-9

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  69 in total

1.  Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing.

Authors:  Nesrin Dogan; Stephanie King; Bahman Emami; Najeeb Mohideen; Nena Mirkovic; Leonid B Leybovich; Anil Sethi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-12-01       Impact factor: 7.038

Review 2.  Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methods.

Authors:  Peter M L Teo; Brigette B Y Ma; Anthony T C Chan
Journal:  Radiother Oncol       Date:  2004-11       Impact factor: 6.280

3.  Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns.

Authors:  To-Wai Leung; Stewart Yuk Tung; Wing-Kin Sze; Frank Chi-Shing Wong; Kwok-Keung Yuen; Collin Ming-Ming Lui; Sing-Hung Lo; Ting-Ying Ng; Sai-Ki O
Journal:  Head Neck       Date:  2005-07       Impact factor: 3.147

4.  Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).

Authors:  Peter M L Teo; Sing Fai Leung; Stewart Y Tung; Benny Zee; Jonathan S T Sham; Anne W M Lee; Wai Hon Lau; Wing Hong Kwan; To Wai Leung; Daniel Chua; Wai Man Sze; Joseph S K Au; Kwok Hung Yu; Sai Ki O; Dora Kwong; Tsz Kok Yau; Stephen C K Law; Wing Kin Sze; Gordon Au; Anthony T C Chan
Journal:  Radiother Oncol       Date:  2006-04-19       Impact factor: 6.280

Review 5.  Analysis of prognostic factors and proposal of a new classification for nasopharyngeal cancer.

Authors:  C Grandi; P Boracchi; G Mezzanotte; M Squadrelli; E Marubini; R Molinari
Journal:  Head Neck       Date:  1990 Jan-Feb       Impact factor: 3.147

6.  Management of local residual primary lesion of nasopharyngeal carcinoma: II. Results of prospective randomized trial on booster dose.

Authors:  J H Yan; G Z Xu; Y H Hu; S Y Li; Y Z Lie; D X Qin; X L Wu; X Z Gu
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-02       Impact factor: 7.038

7.  Nasopharyngeal cancer: study II.

Authors:  S Huang; G Chu
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-06       Impact factor: 7.038

8.  Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60.

Authors:  S C Huang
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-04       Impact factor: 7.038

9.  Prognostic value of Chinese race in nasopharyngeal cancer.

Authors:  Catherine K Su; C C Wang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-01       Impact factor: 7.038

10.  [Analysis of prognostic factors in 106 cases of carcinoma of the rhinopharynx treated with cobalt teletherapy].

Authors:  G Zini; G Alberti; L Armaroli; E Barbieri; G Di Marzio; G Frezza; S Neri; M Silvano; L Babini
Journal:  Radiol Med       Date:  1989-11       Impact factor: 3.469

View more
  2 in total

1.  Nasopharyngeal carcinoma in a low incidence European area : A prospective observational analysis from the Head and Neck Study Group of the Italian Society of Radiation Oncology (AIRO).

Authors:  S Tonoli; D Alterio; O Caspiani; A Bacigalupo; F Bunkheila; M Cianciulli; A Merlotti; A Podhradska; M Rampino; D Cante; L Bruschieri; R Gatta; S M Magrini
Journal:  Strahlenther Onkol       Date:  2016-10-19       Impact factor: 3.621

2.  Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment.

Authors:  Francesco Moretto; Monica Rampino; Fernando Munoz; Maria Grazia Ruo Redda; Alessia Reali; Vittoria Balcet; Serena Badellino; Cristina Piva; Marina Schena; Mario Airoldi; Oliviero Ostellino; Giancarlo Pecorari; Riccardo Ragona; Umberto Ricardi
Journal:  Radiol Med       Date:  2014-01-15       Impact factor: 3.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.